CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:SHP2 in tumor-associated macrophages prompted the progression of colorectal cancer via modulating STAT3/PI3K signaling induced PD-1-mediated CAR-T cell apoptosis.
SHP2 in tumor-associated macrophages prompted the progression of colorectal cancer via modulating STAT3/PI3K signaling induced PD-1-mediated CAR-T cell apoptosis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本研究旨在探讨肿瘤相关巨噬细胞中的酪氨酸磷酸酶对结直肠癌(CRC)进展的影响及其机制。研究通过生物信息学分析CRC中特异表达的基因,并将CRC细胞系SW480与THP-1巨噬细胞共培养;采用荷瘤裸鼠模型检测SHP2对CRC的影响。通过Western blot检测THP-1细胞中p-SHP2、p-STAT3、p-PI3K、p-Src、MMP2、MMP9、Cyclin D1、CD9、TSG101、CD63、PD-L1、Cyclin A和PCNA的相对表达水平;采用细胞迁移及Transwell迁移和侵袭实验评估SW480细胞迁移、侵袭能力,并通过克隆形成实验检测其增殖能力。研究还构建CRC细胞系SW480、THP-1巨噬细胞和CAR-T 细胞共培养体系,以Western blot检测CAR-T 细胞中的Bax、Caspase-3和Caspase-9,并通过免疫荧光检测Bax相对荧光强度。生物信息学分析发现SHP2在CRC中特异性高表达。THP-1细胞中特异性过表达SHP2可促进p-STAT3、p-PI3K、p-Src、MMP2、MMP9、Cyclin D1、Cyclin A和PCNA表达,也提高外泌体中CD9、TSG101、CD63和PD-L1表达,并增强SW480细胞增殖、迁移和侵袭能力。
此外,SHP2可促进CAR-T 细胞中Bax、Caspase-3和Caspase-9表达。肿瘤相关巨噬细胞内SHP2激活与STAT3/PI3K信号上调及PD-1相关CAR-T 细胞凋亡显著相关,提示其参与塑造CRC免疫抑制性微环境并推动疾病进展。
本研究为以巨噬细胞SHP2作为优化免疫治疗切入点提供了有力依据。
To investigate the effect of tumor-associated macrophage tyrosine phosphatase on the progression of colorectal cancer(CRC) and its mechanism. Bioinformatics analysis was used to analyse genes specifically expressed in CRC; The SW480 cell line of CRC and THP-1 macrophages were co-cultured. The effect of SHP2 on CRC was tested by tumor-bearing nude mice model. The relative expression levels of p-SHP2, p-STAT3, p-PI3K, p-Src, MMP2, MMP9, Cyclin D1, CD9, TSG101, CD63, PD-L1,Cyclin A and PCNA in THP-1 cells were detected by Western blot.
Cell migration assay and Transwell migration and invasion assay were performed to examine the migration and invasion ability of SW480 cells, and monoclonal proliferation assay was used to detect the proliferation ability of SW480 cells. A co-culture system of CRC cell line SW480, macrophages THP-1 and CAR-T cells was constructed, and the expression of Bax, Caspase-3 and Caspase-9 in CAR-T cells was detected by Western blot.
In addition, the relative fluorescence intensity of Bax in CAR-T cells was detected by immunofluorescence staining. Bioinformatics analysis found that SHP2 is highly expressed specifically in CRC; Specific overexpression of SHP2 in THP-1 cells could promote the expression of p-STAT3, p-PI3K, p-Src, MMP2, MMP9, Cyclin D1, Cyclin A and PCNA as well as the expression of CD9, TSG101, CD63 and PD-L1 in exosomes, and promote the proliferation, migration and invasion ability of SW480 cells.
In addition, SHP2 can promote the expression of Bax, Caspase-3 and Caspase-9 in CAR-T cells. Activation of TAM-intrinsic SHP2 is significantly associated with upregulation of STAT3/PI3K signaling and PD-1-related CAR-T cell apoptosis, suggesting that it participates in shaping the immunosuppressive microenvironment of CRC and promoting disease progression.
This study provides strong rationale for leveraging macrophage SHP2 as an entry point to optimize immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。